相似文献
1
Analysis of peptidoglycan precursors in vancomycin-resistant enterococci.
Antimicrob Agents Chemother. 1992 Jul;36(7):1487-90. doi: 10.1128/AAC.36.7.1487.
2
The cytoplasmic peptidoglycan precursor of vancomycin-resistant Enterococcus faecalis terminates in lactate.
J Bacteriol. 1992 Sep;174(18):5982-4. doi: 10.1128/jb.174.18.5982-5984.1992.
3
Modified peptidoglycan precursors produced by glycopeptide-resistant enterococci.
FEMS Microbiol Lett. 1992 Jul 1;73(1-2):195-200. doi: 10.1016/0378-1097(92)90608-q.
4
Presence of UDP-N-acetylmuramyl-hexapeptides and -heptapeptides in enterococci and staphylococci after treatment with ramoplanin, tunicamycin, or vancomycin.
J Bacteriol. 1997 Aug;179(15):4684-8. doi: 10.1128/jb.179.15.4684-4688.1997.
5
Control of peptidoglycan synthesis in vancomycin-resistant enterococci: D,D-peptidases and D,D-carboxypeptidases.
Cell Mol Life Sci. 1998 Apr;54(4):325-31. doi: 10.1007/s000180050159.
6
Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type Enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Enterococcus gallinarum.
J Bacteriol. 1994 Apr;176(8):2398-405. doi: 10.1128/jb.176.8.2398-2405.1994.
7
Analysis of peptidoglycan precursors in vancomycin-resistant Enterococcus gallinarum BM4174.
Biochem J. 1994 Jul 1;301 ( Pt 1)(Pt 1):5-8. doi: 10.1042/bj3010005.
8
Biosynthesis of modified peptidoglycan precursors by vancomycin-resistant Enterococcus faecium.
FEMS Microbiol Lett. 1992 Nov 1;77(1-3):109-15. doi: 10.1016/0378-1097(92)90140-j.
9
Inducible and constitutive expression of resistance to glycopeptides and vancomycin dependence in glycopeptide-resistant Enterococcus avium.
Antimicrob Agents Chemother. 1995 Apr;39(4):830-3. doi: 10.1128/AAC.39.4.830.
10
Gene vanXYC encodes D,D -dipeptidase (VanX) and D,D-carboxypeptidase (VanY) activities in vancomycin-resistant Enterococcus gallinarum BM4174.
Mol Microbiol. 1999 Oct;34(2):341-9. doi: 10.1046/j.1365-2958.1999.01604.x.
引用本文的文献
1
Regulation of Resistance in Vancomycin-Resistant Enterococci: The VanRS Two-Component System.
Microorganisms. 2021 Sep 25;9(10):2026. doi: 10.3390/microorganisms9102026.
2
Effect of Vancomycin on Cytoplasmic Peptidoglycan Intermediates and Operon mRNA Levels in VanA-Type Vancomycin-Resistant Enterococcus faecium.
J Bacteriol. 2021 Jul 22;203(16):e0023021. doi: 10.1128/JB.00230-21.
3
Hidden Mode of Action of Glycopeptide Antibiotics: Inhibition of Wall Teichoic Acid Biosynthesis.
J Phys Chem B. 2017 Apr 27;121(16):3925-3932. doi: 10.1021/acs.jpcb.7b00324. Epub 2017 Apr 14.
4
Quantification of the d-Ala-d-Lac-Terminated Peptidoglycan Structure in Vancomycin-Resistant Enterococcus faecalis Using a Combined Solid-State Nuclear Magnetic Resonance and Mass Spectrometry Analysis.
Biochemistry. 2017 Jan 31;56(4):612-622. doi: 10.1021/acs.biochem.6b00774. Epub 2017 Jan 17.
5
vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium.
Antimicrob Agents Chemother. 2010 Nov;54(11):4643-7. doi: 10.1128/AAC.01710-09. Epub 2010 Aug 23.
6
Mechanism of intrinsic resistance to vancomycin in Clostridium innocuum NCIB 10674.
J Bacteriol. 2004 Jun;186(11):3415-22. doi: 10.1128/JB.186.11.3415-3422.2004.
7
Mechanism of action of the mannopeptimycins, a novel class of glycopeptide antibiotics active against vancomycin-resistant gram-positive bacteria.
Antimicrob Agents Chemother. 2004 Mar;48(3):728-38. doi: 10.1128/AAC.48.3.728-738.2004.
8
The CroRS two-component regulatory system is required for intrinsic beta-lactam resistance in Enterococcus faecalis.
J Bacteriol. 2003 Dec;185(24):7184-92. doi: 10.1128/JB.185.24.7184-7192.2003.
9
Peptidoglycan structure of Lactobacillus casei, a species highly resistant to glycopeptide antibiotics.
J Bacteriol. 1997 Oct;179(19):6208-12. doi: 10.1128/jb.179.19.6208-6212.1997.
10
Presence of UDP-N-acetylmuramyl-hexapeptides and -heptapeptides in enterococci and staphylococci after treatment with ramoplanin, tunicamycin, or vancomycin.
J Bacteriol. 1997 Aug;179(15):4684-8. doi: 10.1128/jb.179.15.4684-4688.1997.
本文引用的文献
1
Reverse-phase high-pressure liquid chromatography of uridine diphosphate N-acetylmuramyl peptide precursors of bacterial cell wall peptidoglycan.
Anal Biochem. 1981 Jun;114(1):59-63. doi: 10.1016/0003-2697(81)90451-6.
2
Complete analysis of cellular nucleotides by two-dimensional thin layer chromatography.
J Biol Chem. 1982 Aug 25;257(16):9759-69.
3
Cytoplasmic steps of peptidoglycan synthesis in Escherichia coli.
J Bacteriol. 1982 Sep;151(3):1109-17. doi: 10.1128/jb.151.3.1109-1117.1982.
4
Release of D-alanyl-D-alanine from the precursor of the cell wall peptidoglycan by a peptidase of Escherichia coli K 12.
Biochimie. 1973;55(6):685-91. doi: 10.1016/s0300-9084(73)80022-7.
5
Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium.
N Engl J Med. 1988 Jul 21;319(3):157-61. doi: 10.1056/NEJM198807213190307.
6
Inducible resistance to vancomycin in Enterococcus faecium D366.
J Infect Dis. 1989 Jun;159(6):1095-104. doi: 10.1093/infdis/159.6.1095.
7
Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256.
Antimicrob Agents Chemother. 1989 Feb;33(2):198-203. doi: 10.1128/AAC.33.2.198.
8
The VANA glycopeptide resistance protein is related to D-alanyl-D-alanine ligase cell wall biosynthesis enzymes.
Mol Gen Genet. 1990 Dec;224(3):364-72. doi: 10.1007/BF00262430.
9
Purification and characterization of the D-alanyl-D-alanine-adding enzyme from Escherichia coli.
Biochemistry. 1990 Mar 6;29(9):2379-86. doi: 10.1021/bi00461a023.
10
Resistance to vancomycin and teicoplanin: an emerging clinical problem.
Clin Microbiol Rev. 1990 Jul;3(3):280-91. doi: 10.1128/CMR.3.3.280.
Zotero 插件